Literature DB >> 29185098

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial.

Daniel Rea1, Adele Francis2, Matthew Wallis3, Jeremy Thomas4, John Bartlett5, Sarah Bowden6, David Dodwell7, Lesley Fallowfield8, Claire Gaunt6, Andrew Hanby9, Valerie Jenkins8, Lucy Matthews8, Sarah Pinder10, Sarah Pirrie6, Malcolm Reed11, Margaret Wilcox12, Tracy Roberts13, Cliona Kirwan14, Cassandra Brookes15, Patricia Fairbrother12, Lucinda Billingham6, Andrew Evans16, Jennie Young6.   

Abstract

Mesh:

Year:  2017        PMID: 29185098     DOI: 10.1245/s10434-017-6174-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Authors:  Serdar Altinay; Laurent Arnould; Noella Bletard; Cecile Colpaert; Franceska Dedeurwaerdere; Benjamin Dessauvagie; Valérie Duwel; Giuseppe Floris; Stephen Fox; Clara Gerosa; Shabnam Jaffer; Eline Kurpershoek; Magali Lacroix-Triki; Andoni Laka; Kathleen Lambein; Gaëtan Marie MacGrogan; Caterina Marchió; Dolores Martin Martinez; Sharon Nofech-Mozes; Dieter Peeters; Alberto Ravarino; Emily Reisenbichler; Erika Resetkova; Souzan Sanati; Anne-Marie Schelfhout; Vera Schelfhout; Abeer M Shaaban; Renata Sinke; Claudia Maria Stanciu-Pop; Claudia Stobbe; Carolien H M van Deurzen; Koen Van de Vijver; Anne-Sophie Van Rompuy; Stephanie Verschuere; Anne Vincent-Salomon; Hannah Wen; Hélène Dano; Caroline Bouzin; Christine Galant; Mieke R Van Bockstal
Journal:  Mod Pathol       Date:  2019-09-18       Impact factor: 7.842

Review 2.  Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?

Authors:  Gábor Cserni; Anita Sejben
Journal:  Pathol Oncol Res       Date:  2019-11-27       Impact factor: 3.201

Review 3.  A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.

Authors:  Mieke R Van Bockstal; Marie C Agahozo; Linetta B Koppert; Carolien H M van Deurzen
Journal:  Int J Cancer       Date:  2019-05-08       Impact factor: 7.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.